U.S. Markets closed

Director/PDMR Shareholding

Director/PDMR Shareholding

20 December, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG)

Notification of transactions by persons discharging managerial responsibilities

1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Susan Kilsby
2. Reason for the notification
a) Position / status Chairman – PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Ms. Kilsby’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 164
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Olivier Bohuon
2. Reason for the notification
a) Position / status Senior Independent Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
 
 
Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Acquisition of Ordinary Shares, being the part of Mr. Bohuon’s total fees that are paid in Ordinary Shares for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
£ 44.31 140
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction LSE (TRQX)


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Ian Clark
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Mr. Clark’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 44
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Gail Fosler
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Ms. Fosler’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 47
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Steven Gillis
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Dr. Gillis’ total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 49
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name David Ginsburg
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Dr. Ginsburg’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 44
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Sara Mathew
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Ms. Mathew’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 46
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX


1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Albert Stroucken
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc American Depositary Shares (“ADSs”)
 
 
Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs, being the part of Mr. Stroucken’s total fees that are paid in ADSs for the period of service from October 1 to December 31, 2018.
c) Price(s) and volume(s) Price(s) Volume(s)
$ 168.0470 63
d) Aggregated information

- Aggregated volume - Price
N/A (single transaction)
 
 
 
e) Date of the transaction December 19, 2018
f) Place of the transaction XNAS / XBOS / ARCX

Sarah Rixon
Senior Company Secretarial Assistant

For further information please contact:

Investor Relations    
Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29
Sun Kim sun.kim@shire.com +1 617 588 8175
Scott Burrows scott.burrows@shire.com +41 41 288 4195
     
Media    
Katie Joyce kjoyce@shire.com  +1 781 482 2779
     

NOTES TO EDITORS

About Shire

Shire is the global biotechnology leader serving patients with rare diseases and specialized conditions. We seek to push boundaries through discovering and delivering new possibilities for patient communities who often have few or no other champions. Relentlessly on the edge of what’s next, we are serial innovators with a diverse pipeline offering fresh thinking and new hope. Serving patients and partnering with healthcare communities in over 100 countries, we strive to be part of the entire patient journey to enable earlier diagnosis, raise standards of care, accelerate access to treatment, and support patients. Our diverse portfolio of therapeutic areas includes Immunology, Hematology, Genetic Diseases, Neuroscience, Internal Medicine, and Ophthalmics.
 
Championing patients is our call to action - it brings the opportunity - and responsibility - to change people’s lives.

www.shire.com